(Q38298448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Marco Sebastiani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

6

Poupak Fallahi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Alessia Piluso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Dilia Giuggioli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Alessandro Antonelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Clodoveo Ferri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Anna Linda Zignego

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

15-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus (HCV) infection: a systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The hepatitis C virus infection as a systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Infection of peripheral mononuclear blood cells by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus lymphotropism: lessons from a decade of studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Non-Hodgkin's lymphoma: possible role of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus-related lymphoproliferative disorders: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HCV and lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus core protein enhances B lymphocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Involvement of PI3K in HCV-related lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

T(14;18) translocation in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Random aneuploidy in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Ethnic difference in the prevalence of monoclonal B-cell proliferation in patients affected by hepatitis C virus chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C-associated B-cell non-Hodgkin lymphomas: the emerging role of miRNA-26b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

21 January 2018

Mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Role of the HLA class II: HCV-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The global burden of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

B-cells and mixed cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Preliminary classification criteria for the cryoglobulinaemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Emergency in cryoglobulinemic syndrome: what to do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Extrahepatic manifestations of HCV infection: facts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection and B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Chronic hepatitis C and B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus and non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HCV and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HCV and HGV in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

The non-Hodgkin lymphomas: a review of the epidemiologic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Regression of B-cell lymphoma of the liver with hepatitis C virus infection after treatment with pegylated interferon-alpha and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Regression of Hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Endocrine manifestations of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Hepatitis C virus infection: evidence for an association with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Prevalence of hypothyroidism and Graves disease in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2015.997214

10.1586/1744666X.2015.997214

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25534977%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference